“…Patients with CP undergoing TP are candidates for islet transplantation. 17 At the University of Minnesota, candidates for TP-IAT must have abdominal pain for more than 6 months with impaired quality of life (e.g., inability to work, inability to participate in ordinary activities, repeated hospitalizations, or constant need for narcotics, each coupled with failure to respond to maximal medical treatment or endoscopic pancreatic duct drainage procedures). There must also be objective findings of CP, including at least one of the following: pancreas calcifications on CT scan, abnormal endoscopic retrograde cholangiopancreatography, or at least six of nine criteria on endoscopic ultrasound; any two of the following: ductal or parenchymal abnormalities on secretin-stimulated magnetic resonance cholangiopancreatography, endoscopic ultrasound of pancreas with six of nine criteria positive, or abnormal pancreatic function tests with peak bicarbonate of less than 80 mmol/L; or histopathologic-confirmed diagnosis of CP from previous operations; or hereditary pancreatitis (PRSS1 gene mutation, SPINK1 gene mutation, CFTR gene mutations) with a compatible clinical history; or history of recurrent acute pancreatitis with more than episodes of pain associated with imaging diagnosis of acute pancreatitis and/or elevated serum amylase or lipase three times normal.…”